BSE’s Surveillance Department (DOSS) issued Notice No. 20260424-15 on April 24, 2026, to verify news articles published across newspapers, websites, and television channels. The Exchange sought clarifications from three companies — Dr Reddy’s Laboratories Ltd, Nippon Life India Asset Management Ltd, and IDBI Bank Ltd. Replies have been received from Dr Reddy’s and Nippon Life AMC, while a response from IDBI Bank is still awaited.

Key Points

• BSE contacted three companies for clarifications on media reports as part of its investor protection and market surveillance mandate.
• Dr Reddy’s Laboratories Ltd (Scrip Code: 500124) clarification related to a CNBC TV18 article; reply received.
• Nippon Life India Asset Management Ltd (Scrip Code: 540767) clarification related to an Economic Times legal report; reply received.
• IDBI Bank Ltd (Scrip Code: 500116) clarification related to a Moneycontrol article; reply is still awaited.
• Replies from Dr Reddy’s and Nippon Life AMC are attached to the notice.

Regulatory Changes

No regulatory changes are introduced by this notice. It is a standard surveillance communication under BSE’s ongoing investor information and market integrity framework.

Compliance Requirements

• Companies receiving clarification requests from BSE are required to respond promptly.
• IDBI Bank Ltd is expected to submit its clarification reply to BSE’s Surveillance Department.
• Members and investors are advised to refer to the attached replies for accurate information regarding the news articles in question.

Important Dates

• Notice Date: April 24, 2026
• Clarification replies received: April 24, 2026 (Dr Reddy’s and Nippon Life AMC)
• IDBI Bank reply: Awaited (no deadline specified in notice)

Impact Assessment

This is a routine BSE surveillance action with moderate informational significance. The clarifications from Dr Reddy’s Laboratories and Nippon Life India AMC may address market-moving news and could impact investor sentiment or trading activity in those scrips depending on the content of the replies. The pending response from IDBI Bank (a major public sector bank) leaves some uncertainty until its clarification is published. No trading halts or regulatory actions are indicated at this stage.